{"title":"Some Aspects of Nephrotoxicity of Paracetamol and Ketoprofen in Patients with Rheumathoid Arthritis","authors":"D. Spasovski, S. Genadieva-Stavric, T. Sotirova","doi":"10.1515/mmr-2016-0022","DOIUrl":null,"url":null,"abstract":"Abstract Introduction. To determine the effect of initial therapy with Paracetamol and Ketoprofen on glomerular and tubular integrity in rheumatoid arthritis (RA), to quantify nephrotoxicity of these two drugs by measurement of enzymuria, which correlates with the damage of tubular epithelium. Microalbuminuria is used as a marker for glomerular damage, and urine excretion of N-Acetyl-b-D-glucosaminidase (NAG) as an indicator of proximal tubular damage. Methods. Using colorimetric method for determination of NAG, and immunoturbidimetric method for microalbuminuria, samples of 70 participants were examined (35 RA patients treated with Paracetamol only, 35 RA patients treated with Ketoprofen). The follow-up was in 5 time-intervals in the course of 24 weeks. Results. There was a moderate correlation between NAG and microalbuminuria (r=0.16) in the group of patients treated with Paracetamol only, and a moderate correlation (r=0.28) in the group of patients treated with Ketoprofen. NAG enzymuria in size, by number of patients Registered, and time of appearance, was greater and appeared earlier in the Ketoprofen group compared to the Paracetamol group. Conclusions. Ketoprofen is more potent NAG inductor and provokes greater tubular enzymuria than Paracetamol. Results from our study confirm safety in use of Paracetamol and Ketoprofen in everyday clinical practice.","PeriodicalId":86800,"journal":{"name":"Makedonski medicinski pregled. Revue medicale macedonienne","volume":"70 1","pages":"118 - 124"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Makedonski medicinski pregled. Revue medicale macedonienne","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/mmr-2016-0022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Abstract Introduction. To determine the effect of initial therapy with Paracetamol and Ketoprofen on glomerular and tubular integrity in rheumatoid arthritis (RA), to quantify nephrotoxicity of these two drugs by measurement of enzymuria, which correlates with the damage of tubular epithelium. Microalbuminuria is used as a marker for glomerular damage, and urine excretion of N-Acetyl-b-D-glucosaminidase (NAG) as an indicator of proximal tubular damage. Methods. Using colorimetric method for determination of NAG, and immunoturbidimetric method for microalbuminuria, samples of 70 participants were examined (35 RA patients treated with Paracetamol only, 35 RA patients treated with Ketoprofen). The follow-up was in 5 time-intervals in the course of 24 weeks. Results. There was a moderate correlation between NAG and microalbuminuria (r=0.16) in the group of patients treated with Paracetamol only, and a moderate correlation (r=0.28) in the group of patients treated with Ketoprofen. NAG enzymuria in size, by number of patients Registered, and time of appearance, was greater and appeared earlier in the Ketoprofen group compared to the Paracetamol group. Conclusions. Ketoprofen is more potent NAG inductor and provokes greater tubular enzymuria than Paracetamol. Results from our study confirm safety in use of Paracetamol and Ketoprofen in everyday clinical practice.
摘要介绍。为了确定对乙酰氨基酚和酮洛芬初始治疗对类风湿关节炎(RA)患者肾小球和小管完整性的影响,通过测定与小管上皮损伤相关的酶血症来量化这两种药物的肾毒性。微量白蛋白尿被用作肾小球损伤的标志,尿中n -乙酰-b- d -氨基葡萄糖酶(NAG)的排泄被用作肾小球近端损伤的指标。方法。采用比色法测定NAG和免疫比浊法测定微量白蛋白尿,对70名参与者的样本进行了检查(35名RA患者仅使用扑热息痛治疗,35名RA患者使用酮洛芬治疗)。随访时间为5个时间间隔,共24周。结果。仅使用扑热息痛治疗组NAG与微量白蛋白尿存在中度相关性(r=0.16),使用酮洛芬治疗组NAG与微量白蛋白尿存在中度相关性(r=0.28)。与扑热息痛组相比,酮洛芬组NAG酶的大小(按登记的患者数量和出现时间计算)更大,出现时间更早。结论。酮洛芬是更有效的NAG诱导剂,比扑热息痛引起更大的管状酶。我们的研究结果证实了在日常临床实践中使用扑热息痛和酮洛芬的安全性。